LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Study of SQ109 analogs binding to mycobacterium MmpL3 transporter using MD simulations and alchemical relative binding free energy calculations.

    Stampolaki, Marianna / Stylianakis, Ioannis / Zgurskaya, Helen I / Kolocouris, Antonios

    Journal of computer-aided molecular design

    2023  Volume 37, Issue 5-6, Page(s) 245–264

    Abstract: N-geranyl-N΄-(2-adamantyl)ethane-1,2-diamine (SQ109) is a tuberculosis drug that has high potency against Mycobacterium tuberculosis (Mtb) and may function by blocking cell wall biosynthesis. After the crystal structure of MmpL3 from Mycobacterium ... ...

    Abstract N-geranyl-N΄-(2-adamantyl)ethane-1,2-diamine (SQ109) is a tuberculosis drug that has high potency against Mycobacterium tuberculosis (Mtb) and may function by blocking cell wall biosynthesis. After the crystal structure of MmpL3 from Mycobacterium smegmatis in complex with SQ109 became available, it was suggested that SQ109 inhibits Mmpl3 mycolic acid transporter. Here, we showed using molecular dynamics (MD) simulations that the binding profile of nine SQ109 analogs with inhibitory potency against Mtb and alkyl or aryl adducts at C-2 or C-1 adamantyl carbon to MmpL3 was consistent with the X-ray structure of MmpL3 - SQ109 complex. We showed that rotation of SQ109 around carbon-carbon bond in the monoprotonated ethylenediamine unit favors two gauche conformations as minima in water and lipophilic solvent using DFT calculations as well as inside the transporter's binding area using MD simulations. The binding assays in micelles suggested that the binding affinity of the SQ109 analogs was increased for the larger, more hydrophobic adducts, which was consistent with our results from MD simulations of the SQ109 analogues suggesting that sizeable C-2 adamantyl adducts of SQ109 can fill a lipophilic region between Y257, Y646, F260 and F649 in MmpL3. This was confirmed quantitatively by our calculations of the relative binding free energies using the thermodynamic integration coupled with MD simulations method with a mean assigned error of 0.74 kcal mol
    MeSH term(s) Antitubercular Agents/pharmacology ; Molecular Dynamics Simulation ; Bacterial Proteins/chemistry ; Membrane Transport Proteins/chemistry ; Membrane Transport Proteins/metabolism ; Mycobacterium tuberculosis ; Ethylenediamines/metabolism ; Ethylenediamines/pharmacology
    Chemical Substances Antitubercular Agents ; Bacterial Proteins ; Membrane Transport Proteins ; N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine ; Ethylenediamines
    Language English
    Publishing date 2023-05-02
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 808166-9
    ISSN 1573-4951 ; 0920-654X
    ISSN (online) 1573-4951
    ISSN 0920-654X
    DOI 10.1007/s10822-023-00504-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Improved Synthesis of the Antitubercular Agent SQ109

    Stampolaki, Marianna / Kolocouris, Antonios

    SynOpen

    2021  Volume 05, Issue 04, Page(s) 321–326

    Abstract: We present here an improved procedure for the preparation of the promising antitubercular drug SQ109 that is currently in phase Ib/III of clinical trials against Mycobacterium tuberculosis. We investigated and tested the literature synthetic procedure ... ...

    Abstract We present here an improved procedure for the preparation of the promising antitubercular drug SQ109 that is currently in phase Ib/III of clinical trials against Mycobacterium tuberculosis. We investigated and tested the literature synthetic procedure that enables the development of structure–activity relationships and report the observed inconsistencies as well as presenting improvements or novelties for the more efficient preparation of SQ109. Most significantly we applied a novel reduction step of the aminoamide precursor using Me 3 SiCl­/LiAlH 4 under mild conditions. These findings are important for research groups investigating the efficacy of this drug and analogues in academia and industry.
    Keywords SQ109 ; tuberculosis ; synthesis ; reduction ; trimethylsilyl chloride ; geranylamine ; lithium aluminum hydride
    Language English
    Publishing date 2021-09-27
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ISSN 2509-9396
    ISSN (online) 2509-9396
    DOI 10.1055/a-1655-5867
    Database Thieme publisher's database

    More links

    Kategorien

  3. Article ; Online: Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancer.

    Liolios, Christos / Koutsikou, Theodora S / Salvanou, Evangelia-Alexandra / Kapiris, Fotis / Machairas, Evangelos / Stampolaki, Marianna / Kolocouris, Antonios / Efthimiadou, Eleni Κ / Bouziotis, Penelope

    International journal of pharmaceutics

    2022  Volume 624, Page(s) 122008

    Abstract: Prostate cancer (PCa) is the most common malignancy worldwide in men. This is a proof-of-concept study describing the development ... ...

    Abstract Prostate cancer (PCa) is the most common malignancy worldwide in men. This is a proof-of-concept study describing the development of
    MeSH term(s) Ferric Compounds ; Gallium Radioisotopes ; Humans ; Magnetic Resonance Imaging ; Magnetite Nanoparticles ; Male ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography/methods ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/drug therapy ; Receptors, Bombesin/metabolism ; Spectroscopy, Fourier Transform Infrared
    Chemical Substances Ferric Compounds ; Gallium Radioisotopes ; Magnetite Nanoparticles ; Receptors, Bombesin ; ferric oxide (1K09F3G675)
    Language English
    Publishing date 2022-07-09
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 428962-6
    ISSN 1873-3476 ; 0378-5173
    ISSN (online) 1873-3476
    ISSN 0378-5173
    DOI 10.1016/j.ijpharm.2022.122008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Approaches to primary tert-alkyl amines as building blocks

    Tzitzoglaki, Christina / Drakopoulos, Antonios / Kolocouris, Antonios / Konstantinidi, Athina / Stampolaki, Marianna / Stylianakis, Ioannis

    Tetrahedron. 2019 June 11,

    2019  

    Abstract: Primary tert-alkyl amines include analogues of amantadine, a fragment commonly linked to pharmacophoric groups to enhance biological activity. The preparation of primary tert-alkyl amines is considered to be a difficult problem. Four synthetic procedures, ...

    Abstract Primary tert-alkyl amines include analogues of amantadine, a fragment commonly linked to pharmacophoric groups to enhance biological activity. The preparation of primary tert-alkyl amines is considered to be a difficult problem. Four synthetic procedures, some of which have been previously reported for the synthesis of amines with primary (RCH2NH2) or secondary (RR'CHNH2) alkyl and/or aryl groups, were tested for the synthesis of primary tert-alkyl amines (RR′R′′CNH2) in aliphatic series including adamantane adducts. These procedures included the formation and reduction of tert-alkyl azides, the Ritter reaction in standard and modified conditions, the addition of organometallic reagents to N-tert-butyl sulfinyl ketimines and one-pot reactions between nitriles and organometallic reagents in the presence of a Lewis acid, Τi(iPrO)4 or CeCl3. These synthetic routes are unexplored for primary tert-alkyl amines. Studies on the synthetic routes for primary tert-alkyl amines are currently lacking. The reaction conditions and substrate limitations were studied for each procedure, with the first procedure being the most general and applicable also for compounds bearing bulky adducts.
    Keywords amines ; azides ; bioactive properties ; chemical reactions ; ketimines ; Lewis acids ; moieties ; nitriles ; organic chemistry
    Language English
    Dates of publication 2019-0611
    Publishing place Elsevier Ltd
    Document type Article
    Note Pre-press version
    ZDB-ID 204285-x
    ISSN 1464-5416 ; 0040-4020 ; 0563-2064
    ISSN (online) 1464-5416
    ISSN 0040-4020 ; 0563-2064
    DOI 10.1016/j.tet.2019.06.016
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against

    Stampolaki, Marianna / Malwal, Satish R / Alvarez-Cabrera, Nadine / Gao, Zijun / Moniruzzaman, Mohammad / Babii, Svitlana O / Naziris, Nikolaos / Rey-Cibati, André / Valladares-Delgado, Mariana / Turcu, Andreea L / Baek, Kyung-Hwa / Phan, Trong-Nhat / Lee, Hyeryon / Alcaraz, Mattheo / Watson, Savannah / van der Watt, Mariette / Coertzen, Dina / Efstathiou, Natasa / Chountoulesi, Maria /
    Shoen, Carolyn M / Papanastasiou, Ioannis P / Brea, Jose / Cynamon, Michael H / Birkholtz, Lyn-Marié / Kremer, Laurent / No, Joo Hwan / Vázquez, Santiago / Benaim, Gustavo / Demetzos, Costas / Zgurskaya, Helen I / Dick, Thomas / Oldfield, Eric / Kolocouris, Antonios D

    ACS infectious diseases

    2023  Volume 9, Issue 2, Page(s) 342–364

    Abstract: SQ109 is a tuberculosis drug candidate that has high potency ... ...

    Abstract SQ109 is a tuberculosis drug candidate that has high potency against
    MeSH term(s) Animals ; Humans ; Antitubercular Agents/pharmacology ; Mycobacterium abscessus ; Parasites/metabolism ; Bacterial Proteins/metabolism ; Tuberculosis/microbiology ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/metabolism ; Malaria ; Lipids
    Chemical Substances Antitubercular Agents ; Bacterial Proteins ; Lipids
    Language English
    Publishing date 2023-01-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2373-8227
    ISSN (online) 2373-8227
    DOI 10.1021/acsinfecdis.2c00537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top